Quick Takeaways
- EVENTIDE ASSET MANAGEMENT, LLC filed SCHEDULE 13G/A for VYNE Therapeutics Inc. Common Stock, par value $0.0001 (VYNE).
- Disclosed ownership: 0%.
- Date of event: 30 Sep 2025.
EVENTIDE ASSET MANAGEMENT, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for VYNE Therapeutics Inc. Common Stock, par value $0.0001 (VYNE)
- Filing Manager
- EVENTIDE ASSET MANAGEMENT, LLC
- Reporting Manager
- Eventide Asset Management, LLC
- Symbol
- VYNE
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 15:23:14 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"EVENTIDE ASSET MANAGEMENT, LLC disclosed 0% ownership in VYNE Therapeutics Inc. Common Stock, par value $0.0001 (VYNE) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 14 Aug 2025.
- Current filing was accepted on 14 Nov 2025, 15:23.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Eventide Asset Management, LLC | 0% | 0 | 0 | 0 | /s/ Peter J. Luiso | Peter J. Luiso, General Counsel | |
| Finny Kuruvilla, M.D. Ph. D. | 0% | 0 | 0 | 0 | /s/ Finny Kuruvilla, M.D., Ph. D. | Finny Kuruvilla, M.D., Ph. D. | |
| Robin C. John | 0% | 0 | 0 | 0 | /s/ Robin C. John | Robin C. John |